Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2025-12-25 @ 12:20 AM
NCT ID:
NCT00132158
Eligibility Criteria:
Inclusion Criteria:
* Patient's age is less than or equal to 21 years at the time of study entry.
* Patient has a histologically or pathologically confirmed diagnosis of a recurrent solid tumor that did not respond to standard treatment or one for which there is no known therapy.
* Patient has adequate performance status, along with adequate function of the liver, kidney and bone marrow.
* Must have recovered from chemotherapy
* No active GVHD nor treatment for GVHD
Exclusion Criteria:
* Patient is receiving other cytotoxic or investigational drug or has evidence of another active illness
* Active diarrhea
* Active intercurrent serious or uncontrolled illness
* Pregnant or lactating
* Concomitant use of medications that may interact with study drugs
* Active infection
* Known history of life-threatening allergy or hypersensitivity to camptothecin Active interstitial lung disease
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT00132158
Study Brief:
Protocol Section:
NCT00132158